End AxD funds gene therapy research for Alexander disease

The foundation End AxD, a nonprofit dedicated to research, treatment and a cure for Alexander disease, has donated $74,000 to UMass Chan Medical School to explore a gene therapy treatment for the fatal neurological disease.

Previous
Previous

Webinar Recording Available Now: AAV-medicated Gene Silencing (August 2023)

Next
Next

End AxD is excited to announce two new partnerships with leading universities.